Efficacy of S26308 against guinea pig cytomegalovirus infection.

Prophylactic use of antiviral agents against cytomegalovirus (CMV) is particularly indicated for the immunocompromised host because morbidity and mortality due to CMV occur most frequently following immunosuppression. We have evaluated the new Riker compound S26308 for its therapeutic and prophylact...

Descrición completa

Detalles Bibliográficos

Publicado en:	Antimicrob Agents Chemother
Principais autores:	Chen, M, Griffith, B P, Lucia, H L, Hsiung, G D
Formato:	Artigo
Idioma:	Inglês
Publicado:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172251/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2840014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.5.678
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!